Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS: PVCT · Delayed Price · USD
0.134
+0.002 (1.34%)
May 26, 2023, 3:59 PM EDT - Market closed
PVCT Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for PVCT stock.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for PVCT.
Recommendation Trends
No data available
| Rating | May 2023 |
|---|---|
| Strong Buy | n/a |
| Buy | n/a |
| Hold | n/a |
| Sell | n/a |
| Strong Sell | n/a |
| Total | n/a |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
from -0.01
EPS Next Year
n/a
| Year | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Revenue Growth | - | - | - | - | - |
| EPS | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 |
| EPS Growth | - | - | - | - | - |
| No. Analysts | - | - | - | - | - |
Revenue Forecast
| Revenue |
|---|
| High |
| Avg |
| Low |
Revenue Growth
| Revenue Growth |
|---|
| High |
| Avg |
| Low |
EPS Forecast
| EPS |
|---|
| High |
| Avg |
| Low |
EPS Growth
| EPS Growth |
|---|
| High |
| Avg |
| Low |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.